Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy

ClinicalTrials.gov ID: NCT02503332

Public ClinicalTrials.gov record NCT02503332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients With Geographic Atrophy (GA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of the study are to assess the safety, tolerability and evidence of activity of multiple intravitreal (IVT) injections of pegcetacoplan in subjects with Geographic Atrophy associated with Age-Related Macular Degeneration (AMD).

Study identification

NCT ID
NCT02503332
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Apellis Pharmaceuticals, Inc.
Industry
Enrollment
246 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 24, 2015 (Actual)
Primary completion
Jul 14, 2017 (Actual)
Completion
Jan 17, 2018 (Actual)
Last update posted
Oct 6, 2020

2015 – 2018

United States locations

U.S. sites
35
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Retina Speciality Institute Mobile Alabama 36606 —
Retinal Research Institute Phoenix Arizona 85014 —
Retina Vitreous Asociates Mdical Goup Beverly Hills California 90211 —
The Gavin Herbert Eye Institute/UC Irvine Irvine California 92697 —
University of Southern California - USC Eye Institute Los Angeles California 90033 —
Byers Eye Institute at Stanford, Stanford School of Medicine Palo Alto California 94303 —
New England Retina Associates New London Connecticut 06320 —
Florida Eye Microsurgical Institute, Inc. Boynton Beach Florida 33426 —
Retina Health Center Fort Myers Florida 33907 —
Bascom Palmer Eye Institute Miami Florida 33136 —
South East Retina Augusta Georgia 30909 —
Illinois Retina Associates Harvey Illinois 60426 —
Midwest Eye Institute Indianapolis Indiana 46290 —
Elman Research Baltimore Maryland 21237 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Associated Retinal Consultants PC Grand Rapids Michigan 45946 —
Associated Retinal Consultants, PC Traverse City Michigan 49586 —
Mayo Clinic Rochester Minnesota 55905 —
Eyesight Opthalmic Services PA Portsmouth New Hampshire 03801 —
Vitreous Retina Macula Consultants of New York New York New York 10022 —
Charlotte Eye Ear Nose and Throat Associates Charlotte North Carolina 28210 —
Duke University, Duke Eye Center Durham North Carolina 27705 —
Charlotte Eye Ear Nose and Throat Associates Statesville North Carolina 28677 —
Cleveland Clinic Foundation/ Cole Eye Institute Cleveland Ohio 44106 —
Retina Associates of Cleveland Cleveland Ohio 44122 —
Mid Atlantic Philadelphia Pennsylvania 19006 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Tennessee Retina, PC Nashville Tennessee 37203 —
Retina Research Institute of Texas Abilene Texas 79606 —
Retina Research Center Austin Texas 78705 —
Retina Consultants of Houston Houston Texas 77030 —
Valley Retina Institute, PA McAllen Texas 75803 —
Retina Specialists Plano Texas 75093 —
Retina Consultants of Houston (The Woodlands) The Woodlands Texas 77384 —
University of Utah Salt Lake City Utah 84132 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02503332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2020 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02503332 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →